Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold

Abou El Ella, Dalal; Ismail, Nasser S M; Abouzid, Khaled; Shahin, Mai I.;

Abstract


In an effort to develop ATP-competitive VEGFR-2 selective inhibitors, a series of new quinoxaline-based derivatives was designed and synthesized. The target compounds were biologically evaluated for their inhibitory activity against VEGFR-2. The design of the target compounds was accomplished after a profound study of the structure activity relationship (SAR) of type-II VEGFR-2 inhibitors. Among the synthesized compounds, 1-(2-((4-methoxyphenyl)amino)-3-oxo-3,4 dihydroquinoxalin-6-yl)-3-phenylurea (VIIa) displayed the highest inhibitory activity against VEGFR-2. Molecular modeling study involving molecular docking and field alignment was implemented to interpret the variable inhibitory activity of the newly synthesized compounds.


Other data

Title Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold
Authors Abou El Ella, Dalal ; Ismail, Nasser S M; Abouzid, Khaled ; Shahin, Mai I. 
Keywords Docking study;Kinase;Quinoxaline;Type-II;VEGFR-2
Issue Date Oct-2014
Publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
Journal Bioorganic Chemistry 
Volume 56
Start page 16
End page 26
ISSN 0045-2068
DOI 10.1016/j.bioorg.2014.05.010
PubMed ID 24922538
Scopus ID 2-s2.0-84902130038
Web of science ID WOS:000341425600003

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 8 in pubmed
Citations 72 in scopus
views 23 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.